- Home
- OABI vs ENX Comparison
OABI vs ENX Comparison
Compare OABI & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- ENX
- Stock Information
- Founded
- OABI 2012
- ENX 2002
- Country
- OABI United States
- ENX United States
- Employees
- OABI N/A
- ENX N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- ENX Finance/Investors Services
- Sector
- OABI Health Care
- ENX Finance
- Exchange
- OABI Nasdaq
- ENX Nasdaq
- Market Cap
- OABI 198.2M
- ENX 165.4M
- IPO Year
- OABI N/A
- ENX N/A
- Fundamental
- Price
- OABI $1.66
- ENX $9.26
- Analyst Decision
- OABI Strong Buy
- ENX
- Analyst Count
- OABI 3
- ENX 0
- Target Price
- OABI $7.00
- ENX N/A
- AVG Volume (30 Days)
- OABI 1.1M
- ENX 25.4K
- Earning Date
- OABI 08-07-2025
- ENX 01-01-0001
- Dividend Yield
- OABI N/A
- ENX 3.94%
- EPS Growth
- OABI N/A
- ENX N/A
- EPS
- OABI N/A
- ENX 0.16
- Revenue
- OABI $26,744,000.00
- ENX N/A
- Revenue This Year
- OABI N/A
- ENX N/A
- Revenue Next Year
- OABI $45.65
- ENX N/A
- P/E Ratio
- OABI N/A
- ENX $61.00
- Revenue Growth
- OABI 27.07
- ENX N/A
- 52 Week Low
- OABI $1.22
- ENX $7.84
- 52 Week High
- OABI $4.96
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- OABI 53.98
- ENX 52.65
- Support Level
- OABI $1.55
- ENX $9.13
- Resistance Level
- OABI $1.73
- ENX $9.17
- Average True Range (ATR)
- OABI 0.11
- ENX 0.06
- MACD
- OABI 0.02
- ENX 0.02
- Stochastic Oscillator
- OABI 68.13
- ENX 65.22
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.